A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 7560-7560
Keyword(s):